The global cell surface markers detection market revenue was around US$ 5,019.5 million in 2022 and is estimated to reach US$ 11,055.8 million by 2031, growing at a compound annual growth rate (CAGR) of 9.17% during the forecast period from 2023 to 2031.
Cell surface markers are unique to cell kinds and have a crucial functional role in immunology. They are molecules or antigens present within the plasma membrane of the cell and act as the prime component in the categorization and identification of cells such as macrophages, lymphocytes, monocytes, tumor cells, and other cells related to immunology.
Market Driving Factors
Increasing applications in disease diagnostics to propel the market expansion. For instance, BD Life Sciences-Biosciences and Christian Medical College, Vellore declared the launch of its Center of Excellence (CoE) in flow cytometry for clinical research in India. This CoE will act as the National Reference Center for clinical diagnostics applications.
An increase in cancer cases will support market expansion. For instance, the World Health Organisation (WHO) estimates that cancer will be the primary cause of more than ten million deaths, or roughly 1 in 6. Lung, breast, rectum, colon, and prostate cancers are the most prevalent types of cancer.
Key players in the market and several governments across the globe are concentrating on developing novel/innovative products in the market owing to the rise in the use of cell surface markers detection in technological and diagnostics advances. Moreover, the increase in global disease burden has increased the demand for cell surface markers detection technologies for research and diagnostics applications. Such developments are anticipated to surge the demand for such technologies. Therefore, these elements are fueling the market expansion.
The high price of instruments to restrain the market expansion.
Regional Analysis
North America dominates the market in terms of the share over the forecast period. This is due to the large number of research projects carried out in this region of molecular and cell biology. The higher incidence rate of cancer and other chronic diseases that augment in vitro diagnostics demand is also attributed to this large market share. Additionally, a significant number of key players in the U.S. are involved in technological advances, ultimately presenting new products and devices. Therefore, this factor is contributing to large revenue generation from this region in the market.
Asia Pacific is estimated to dominate the market in terms of the CAGR. This is due to the surge in geriatric population base and enhancements in healthcare infrastructure. Moreover, the rise in government, as well as private investments in the biotechnology sector, are attributed to the lucrative development pattern in this region. Furthermore, supportive government incentives and research grants in developing economies, such as China and India, are expected to raise the demand for reagents and kits useful in cell surface markers technology, thus boosting the market in the region.
Segmentation Insights
Product Insight
Flow cytometry dominates the market in terms of shares. This is due to the advantages associated with the usage of the technique. These advantages include the requirement of multi-parameter and quantitative analysis of lymphocytes, sorting simultaneously, and cell counting.
Application Insight
The drug discovery segment dominates the market in terms of revenue. Cell surface indicators can support the growth of new drugs, especially in personalized medicine. Scientists are starting to progress in creating novel medications due to the capacity to identify individual cells based on surface characteristics. Drugs suitable for these special compounds can then be designed once the targets, carbohydrates, and surface proteins have been identified. For instance, brand-new therapeutic targets are being discovered on the surface of cancer cells. The groups of differentiation act as new targets for chemotherapeutic drugs in addition to being utilized for identification.
Prominent Companies
Segmentation Outline
The global cell surface markers detection market segmentation focuses on Product, Application, and Region.
By Product
By Application
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL CELL SURFACE MARKERS DETECTION MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: CELL SURFACE MARKERS DETECTION MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL CELL SURFACE MARKERS DETECTION MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL CELL SURFACE MARKERS DETECTION MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 FLOW CYTOMETRY
5.3 HEMATOLOGY ANALYSERS
5.4 CELL IMAGING SYSTEMS
5.5 REAGENTS AND KITS
5.6 OTHER PRODUCTS
6 GLOBAL CELL SURFACE MARKERS DETECTION MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 DISEASE DIAGNOSIS AND IDENTIFICATION
6.3 DRUG DISCOVERY
6.4 RESEARCH AND ACADEMIA
6.5 OTHERS
7 GLOBAL CELL SURFACE MARKERS DETECTION MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL CELL SURFACE MARKERS DETECTION MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
8.4 COMPETITIVE DASHBOARD
8.5 PRODUCT MAPPING
8.6 TOP PLAYER POSITIONING, 2022
8.7 COMPETITIVE HEATMAP
8.8 TOP WINNING STRATEGIES
9 COMPANY PROFILES
9.1 GRIFOLS S.A.
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.2 ABBOTT LABORATORIES
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.3 SYSMEX CORPORATION
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.4 AGILENT TECHNOLOGIES INC
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.5 NEXCELOM BIOSCIENCE
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.6 THERMO FISHER SCIENTIFIC INC
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.7 SIEMENS HEALTHINEERS
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.8 NIHON KOHDEN CORPORATION
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.9 F. HOFFMANN-LA ROCHE LTD
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.10 BIO RAD LABORATORIES INC
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
9.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved